MindRank Advances China’s First AI-Assisted Drug to Phase 3 Trials, Slashes R&D Costs by 60% NewsMindRank Advances China’s First AI-Assisted Drug to Phase 3 Trials, Slashes R&D Costs by 60%
MindRank Advances China’s First AI-Assisted Drug to Phase 3 Trials, Slashes R&D Costs by 60%